Viral protein-coating of magnetic nanoparticles using simian virus 40 VP1.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Biotechnology

• Publication date

  2013-08-10

• Fields of study

  Medicine, Chemistry, Engineering

• Identifiers
  DOI 10.1016/j.jbiotec.2013.06.005PMID 23791947
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro reconstitution of SV40 particles that are composed of VP1/2/3 capsid proteins and nucleosomal DNA and direct efficient gene transfer.

  2011cited by this paper
• A two-step ligand exchange reaction generates highly water-dispersed magnetic nanoparticles for biomedical applications

  2011cited by this paper
• Cell selective targeting of a simian virus 40 virus-like particle conjugated to epidermal growth factor.

  2011cited by this paper
• Modified natural nanoparticles as contrast agents for medical imaging.

  2010cited by this paper
• Calcium Bridge Triggers Capsid Disassembly in the Cell Entry Process of Simian Virus 40*

  2009cited by this paper
• Engineering of SV40-based nano-capsules for delivery of heterologous proteins as fusions with the minor capsid proteins VP2/3.

  2008cited by this paper
• Presentation of functional foreign peptides on the surface of SV40 virus-like particles.

  2008cited by this paper
• Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.

  2008cited by this paper
• Evidence that SV40 VP1–DNA interactions contribute to the assembly of 40‐nm spherical viral particles

  2007cited by this paper
• Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems.

  2006cited by this paper
• Mutational analysis of the carboxyl-terminal region of the SV40 major capsid protein VP1.

  2006cited by this paper
• The VP2/VP3 Minor Capsid Protein of Simian Virus 40 Promotes the in Vitro Assembly of the Major Capsid Protein VP1 into Particles*

  2006cited by this paper
• Nanoparticle imaging of integrins on tumor cells.

  2006cited by this paper
• Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles.

  2006cited by this paper
• Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.

  2005cited by this paper
• Simian virus 40 VP1 capsid protein forms polymorphic assemblies in vitro.

  2003cited by this paper
• Tissue-specific MR contrast agents.

  2003influential reference
• Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs): Simple drugs with a complex mechanism of action?

  2003cited by this paper
• Heating the patient: a promising approach?

  2002cited by this paper
• Heating the patient : a promising approach ?

  2002cited by this paper
• The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.

  2001cited by this paper
• Hyperthermia in oncology.

  2001cited by this paper
• Roles of Disulfide Linkage and Calcium Ion-Mediated Interactions in Assembly and Disassembly of Virus-Like Particles Composed of Simian Virus 40 VP1 Capsid Protein

  2001cited by this paper
• In vivo studies of Gd‐DTPA‐monoclonal antibody and gd‐porphyrins: Potential magnetic resonance imaging contrast agents for melanoma

  2001cited by this paper
• Magnetic resonance contrast enhancement of neovasculature with αvβ3‐targeted nanoparticles

  2000cited by this paper
• Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles.

  2000cited by this paper
• Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

  2000cited by this paper
• Inhibition of cancer cell growth by polyinosinic-polycytidylic acid/cationic liposome complex : A new biological activity

  2000cited by this paper
• Cell and molecular biology of simian virus 40: implications for human infections and disease.

  1999cited by this paper
• Inhibition of cancer cell growth by polyinosinic-polycytidylic acid/cationic liposome complex: a new biological activity.

  1999cited by this paper
• Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging.

  1998cited by this paper
• Discovery of simian virus 40 (SV40) and its relationship to poliomyelitis virus vaccines.

  1998cited by this paper
• Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti‐epidermal growth factor receptor antibody

  1998influential reference
• Purification and characterization of virus-like particles and pentamers produced by the expression of SV40 capsid proteins in insect cells.

  1996cited by this paper
• MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis.

  1996cited by this paper
• Epidermal growth factor-related peptides and their receptors in human malignancies.

  1995cited by this paper
• Magnetoferritin: Characterization of a novel superparamagnetic MR contrast agent

  1994cited by this paper
• The Demonstration of Human Tumors on Nude Mice Using Gadolinium‐Labelled Monoclonal Antibodies for Magnetic Resonance Imaging

  1993cited by this paper
• Structure of simian virus 40 at 3.8-Å resolution

  1991cited by this paper
• Site-directed mutation affecting polyomavirus capsid self-assembly in vitro

  1987influential reference
• The effects of total‐body hyperthermia combined with anticancer drugs on immunity in advanced cancer patients

  1983cited by this paper
• Characterization of WiDr: A human colon carcinoma cell line

  1979cited by this paper

• Magnetizing Biotech–Advances in (In Vivo) Magnetic Enzyme Immobilization

  2025cites this paper
• Interferon-γ production in response to the cytotoxic T lymphocyte epitope within an antigen incorporated in simian virus 40 virus-like particles

  2025cites this paper
• Mitomycin loaded self-assembled colloidal prodrug nanoparticles for magnetic drug targeting

  2023cites this paper
• Hybrid Lymphatic Drug Delivery Vehicles as a New Avenue for Targeted Therapy: Lymphatic Trafficking, Applications, Challenges, and Future Horizons

  2023cites this paper
• In Vitro Assembly of Virus-Like Particles and Their Applications

  2021cites this paper
• Self‐Assembly of Proteinaceous Shells around Positively Charged Gold Nanomaterials Enhances Colloidal Stability in High‐Ionic‐Strength Buffers

  2020cites this paper
• Assembly and Stability of Simian Virus 40 Polymorphs.

  2020cites this paper
• Design and biosynthesis of functional protein nanostructures

  2020cites this paper
• Revealing in real-time a multistep assembly mechanism for SV40 virus-like particles

  2020cites this paper
• Induction of adaptive immune responses against antigens incorporated within the capsid of simian virus 40.

  2020cites this paper
• The Role of Virus-Like Particles in Medical Biotechnology.

  2020cites this paper
• Protein Cage Nanoparticles as Delivery Nanoplatforms.

  2018cites this paper
• Particle-Stabilized Fluid-Fluid Interfaces: The Impact of Core Composition on Interfacial Structure

  2018cites this paper
• Effect of dsDNA on the Assembly Pathway and Mechanical Strength of SV40 VP1 Virus-like Particles.

  2018cites this paper
• Virus‐Based Nanoparticles of Simian Virus 40 in the Field of Nanobiotechnology

  2018cites this paper
• Encapsulation of Inorganic Nanomaterials inside Virus-Based Nanoparticles for Bioimaging

  2017influential citation
• Retargeting Polyomavirus-Like Particles to Cancer Cells by Chemical Modification of Capsid Surface.

  2017cites this paper
• Virus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicine.

  2015cites this paper
• Virus-based nanomaterials as PET and MR contrast agents: from technology development to translational medicine

  2015cites this paper
• Encapsulation of Biomolecules in Bacteriophage MS2 Viral Capsids

  2014cites this paper
• Production and applications of engineered viral capsids

  2014cites this paper
• SV40 VP1 major capsid protein in its self-assembled form allows VP1 pentamers to coat various types of artificial beads in vitro regardless of their sizes and shapes

  2014cites this paper
• SV40 virus-like particles as an effective delivery system and a vaccine platform

  2014cites this paper
• Production and biomedical applications of virus-like particles derived from polyomaviruses.

  2013cites this paper